Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic
Andrés Acosta(Mayo Clinic), Matthew M. Clark, Alison Mcrae(Mayo Clinic), Barham Abu Dayyeh(Mayo Clinic), William Rossini(Mayo Clinic), Daniel González(University of North Carolina at Chapel Hill), Sneha Singh(Maharaja Sayajirao University of Baroda), Michael Camilleri(CSIRO Manufacturing), Gerardo Calderón(Mayo Clinic), Duane D. Burton(Mayo Clinic)
Cited by 199
Related Papers
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Intestinal barrier function in health and gastrointestinal disease
|Neurogastroenterology & Motility|2012|886
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
|The Lancet|2021|564